Bellevue Healthcare Share Discussion Threads

[speedsgh] 06/1/2022 14:39

Any idea on the reason for the sudden pullback? Adverse news from one of their holdings?

[tonytyke2] 06/1/2022 12:57

Decided to add more or this pull back this morning. Good luck all!

[tonytyke2] 23/12/2021 00:25

Welcome Sinzu, as per my last post, I added more yesterday. BBH could also be a decent inflation defensive play imo.Have a great Xmas everyone!TT

[sinzu] 22/12/2021 11:58

Bought some today. Looking very strong. A lot of trades reported as sells or unknown are actually buys.

[speedsgh] 03/12/2021 11:16

Target total dividend -

As stated in the Company's IPO prospectus and in the Company's prospectus dated 5 November 2018, the Company aims to target a dividend each financial year equal to 3.5 per cent of the Net Asset Value as at the last day of the Company's preceding financial year.

The Company intends to pay dividends on a semi-annual basis, by way of two equal dividends, with dividends declared in July and paid in August / September and proposed in February / March and paid in March / April in each year.

For the financial year ended 30 November 2021 the Company paid an interim dividend of 3.015p per ordinary share in September 2021 and in due course the Board is intending to propose a final dividend of 3.015p per ordinary share.

For the financial year ending 30 November 2022, the target total dividend will be 6.47p per ordinary share, this being 3.5 per cent of the unaudited net asset value per ordinary share of 184.91p per ordinary share (including current financial year revenue items) as at 30 November 2021. The Board intends to declare an interim dividend of 3.235p per ordinary share, being half of the target total dividend for the financial year ending 30 November 2022, in July 2022 and intends to pay this dividend in August / September 2022. The Board intends to propose a final dividend of 3.235p per ordinary share for the financial year ending 30 November 2022, in February / March 2023 and intends to pay this dividend in March / April 2023.

Randeep Grewal, Chairman, commented:
The Board is pleased to announce that this is the fifth consecutive year of dividend growth for the Company, with an 84.9% increase in distributions over the past five years and a 7.3% increase on last year's level of distribution.

[tonytyke2] 14/11/2021 22:50

Yep, cracking investment here, topped yet again recently, this was originally chosen for my defensive portfolio.But wow, what growth and yield! Now freeing up funds to add further. Good luck to all holders.

[wad collector] 11/11/2021 22:19

Ignoring the inital Covid drop , what an impressive looking chart. Doubled in 5 yrs, reasonable yield, happy to continue to hold.

[speedsgh] 29/10/2021 11:54

Mention of BBH in this IC article earlier this week...

Get a boost from lucrative health technology -

[mw8156] 08/9/2021 19:37

hrc, one of their top holdings, being acquired by Baxter

[rambutan2] 08/9/2021 19:11

Latest monthly:

[hectorscrackhouse] 25/8/2021 10:52

Yes, Tony, I had emailed the investor relations and repeated the gesture today.

Apparently,
they do not disclose the portfolio outside of top 10 because of a decision by the independent trust board at launch as a number of institutions replicated the portfolio when holdings were disclosed impacting share prices particularly in small/mid cap names.

But they are about to launch an open ended UK OEIC version of BBH and will disclose full portfolio on a semi annual basis.

[tonytyke2] 20/8/2021 14:05

Hectorscrackhouse, I would email their investor relations team to request.By the way, John Baron in today's IC indicates increasing exposure to healthcare in his portfolios. His 2 favoured holdings are BBH & WWH.

[hectorscrackhouse] 10/8/2021 08:45

Does anyone have a complete list of their holdings?

The 12 I have identified are the following, mainly gleaned from their factsheets. Anyone have others to add?

BMY
HRC
VRTX
JAZZ
INSM
ANTM
ALNY
HUM
BIO
OPCH
CRL
ACCD

[speedsgh] 09/4/2021 14:31

Citywire podcast (40m31s). Transcript of podcast also available lower down the page on the following link...

Covid-19: What does the future of vaccination look like now? -

Citywire’s Gavin Lumsden talks to Paul Major, fund manager of BB Healthcare (BBH) investment trust; Dr Annalisa Jenkins, former chief executive of Dimension Therapeutics; and Professor Justin Stebbing, professor of cancer medicine and oncology at Imperial College London and a non-executive director of BBH, about the scientific, political and societal challenges in keeping coronavirus at bay.

This is the second in a series of three Funds Fanatic podcasts in association with BB Healthcare. The first looked at the ‘global collaboration that will help us defeat Covid-19’ -

[pob69] 10/3/2021 10:35

Interesting blog post

[jonwig] 08/7/2020 06:07

Always an entertaining and instructive read! They seem to enjoy writing their reports, unlike the dry-as-dust stuff you usually see.

[rambutan2] 08/7/2020 02:41

Yes, it did make it into the 250, and continues to grow with 461,750,000 shares now in issue.

June fact sheet:

[rambutan2] 18/5/2020 02:41

Just realised that this is headed for a spot in the FTSE 250 at the June 3 review.

[jonwig] 26/3/2019 06:47

Citywire on management changes:

[jonwig] 06/11/2018 08:50

Thankls Eberhardt - if you register you get two free articles a week (that's good enough for me usually:

BB Healthcare Trust reckons last month’s market sell-off is too much of an opportunity to miss. The investment trust pressed ahead with a share issue programme yesterday that could mean it raises more than its current market value over the next 12 months. It argued that the October fall in prices had a disproportionately high effect on the kinds of smaller, high-growth companies it invests in and there are stockpicking deals to be had.

BB Healthcare may actually be one itself. Its shares have lost 9 per cent since the beginning of October, against a drop of 4.5 per cent in the wider MSCI Healthcare index that it benchmarks itself against. The company is worth a closer look.

BB Healthcare was listed in December 2016 and is managed by Bellevue Asset Management, a Swiss-based group that came up with the idea of a specialist healthcare investment trust after it encountered investment constraints with an existing, much larger biotech fund.

Its brief is to invest in listed healthcare companies worldwide based on no criteria other than potential future value. It has limited itself to a maximum of 35 holdings and in practice 94 per cent of its portfolio is with American companies, hardly surprising given the entrepreneurial role of the private sector in healthcare provision with a regulator that is keen to foster innovation in treatments.

Among its largest investments is Anthem, a health insurance company formerly known as Wellpoint; Teladoc, a phone-based healthcare provider; and Illumina, a technology-driven group whose products are used in genetic analysis.

The fund tries to ensure all of its funds are invested at any one time but regularly issues new stock to fund growth, unafraid to quadruple its size in the coming years from its current £430 million. Its facility yesterday authorised it to issue as many as 345 million new shares over the next 12 months, worth a little more than £470 million, based on yesterday’s price, up 1p to 135½p.

Its strategy of investing in huge structural changes in worldwide health provision against the backdrop of our longer lives, better treatments for chronic diseases and the rise of private care is interesting.
ADVICE Buy for the long term
WHY Proven in profiting from healthcare’s structural changes

[eberhardt] 06/11/2018 08:35

According Tempus in The Times today BBH is a buy for the long term. Not a subscriber so can't give full link.
Reported in the news summary in Citywire
hxxps://citywire.co.uk/money/tuesday-papers-brussels-to-offer-border-compromise/a1172662?ref=citywire-money-latest-news-list

[jonwig] 05/11/2018 07:09

Issue of equity, including placing, open offer, intermediaries offer:



"The issue price per Ordinary Share of any shares issued pursuant to the Initial Issue will be at a premium of 2% to the unaudited NAV per Ordinary Share (cum income) on the day that the Initial Placing closes, which is expected to be 28 November 2018. "

[jonwig] 28/8/2018 09:10

Woodford's mistake was taking big stakes in small companies, then getting stuck and unable to unload his losers. His stock-picking skills are poor, though.

[semper vigilans] 28/8/2018 08:55

At the moment.....?

[toffeeman] 28/8/2018 08:52

they are too small for BBH